Pollard; Matthew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pollard; Matthew.The latest application filed is for "interferon alpha 2b variants".
Company Profile
10.19.28
- Pollard; Matthew - Macquarie Park AU
- Pollard; Matthew - Pullenvale AU
- POLLARD; Matthew - Dural AU
- Pollard; Matthew - Swarthmore PA
- Pollard; Matthew - Cheshire GB
- Pollard; Matthew - Moscow ID
Patent Activity
| Patent | Date |
|---|---|
| Interferon Alpha 2b Variants App 20220220184 - Behrens; Collette ; et al. | 2022-07-14 |
| Antibodies That Specifically Bind To TL1A App 20220185902 - POULTON; Lynn Dorothy ; et al. | 2022-06-16 |
| Anti-CXCR2 antibodies and uses thereof Grant 11,332,534 - Shim Siew Chen , et al. May 17, 2 | 2022-05-17 |
| Interferon alpha 2B variants Grant 11,319,356 - Behrens , et al. May 3, 2 | 2022-05-03 |
| Antibodies That Specifically Bind To Human Il-15 And Uses Thereof App 20220127352 - LAINE; David Jose Simon ; et al. | 2022-04-28 |
| Antibodies that specifically bind to human IL-15 and uses thereof Grant 11,267,883 - Laine , et al. March 8, 2 | 2022-03-08 |
| Anti-par-2 Antibodies And Methods Of Use Thereof App 20220056125 - BRACKEN; Anna Mikaela ; et al. | 2022-02-24 |
| Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases Grant 11,220,549 - Poulton , et al. January 11, 2 | 2022-01-11 |
| Antibodies Against Tl1a And Uses Thereof App 20210347904 - POULTON; Lynn Dorothy ; et al. | 2021-11-11 |
| Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B Grant 11,117,975 - Clarke , et al. September 14, 2 | 2021-09-14 |
| Fusions of antibodies to CD38 and attenuated interferon alpha Grant 10,981,986 - Wilson, Jr. , et al. April 20, 2 | 2021-04-20 |
| Antibody variants transmigrating the blood-brain barrier and uses thereof Grant 10,906,973 - Stanimirovic , et al. February 2, 2 | 2021-02-02 |
| Antibodies against TL1a and uses thereof Grant 10,822,422 - Poulton , et al. November 3, 2 | 2020-11-03 |
| Antibodies That Specifically Bind To Human Il-15 And Uses Thereof App 20200270339 - LAINE; David Jose Simon ; et al. | 2020-08-27 |
| Metamodel For Graph Database App 20200110776 - Pollard; Matthew | 2020-04-09 |
| Interferon Alpha 2b Variants App 20200102364 - Behrens; Collette ; et al. | 2020-04-02 |
| Antibody Variants Transmigrating The Blood-brain Barrier And Uses Thereof App 20200095316 - Stanimirovic; Danica ; et al. | 2020-03-26 |
| Anti-cxcr2 Antibodies And Uses Thereof App 20200040089 - Shim Siew Chen; Doris ; et al. | 2020-02-06 |
| Interferon alpha 2B variants Grant 10,544,199 - Behrens , et al. Ja | 2020-01-28 |
| Antibodies That Specifically Bind To TL1A App 20190106486 - Poulton; Lynn Dorothy ; et al. | 2019-04-11 |
| Antibodies that specifically bind to TL1A Grant 10,138,296 - Poulton , et al. Nov | 2018-11-27 |
| Anti-cd38 Antibodies And Fusions To Attenuated Interferon Alpha-2b App 20180305460 - Clarke; Adam ; et al. | 2018-10-25 |
| Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B Grant 9,963,515 - Clarke , et al. May 8, 2 | 2018-05-08 |
| Fusions Of Antibodies To Cd38 And Attenuated Interferon Alpha App 20170233449 - Wilson, Jr.; David S. ; et al. | 2017-08-17 |
| Fusions of antibodies to CD38 and attenuated interferon alpha Grant 9,611,322 - Wilson, Jr. , et al. April 4, 2 | 2017-04-04 |
| Antibodies That Specifically Bind To Tl1a App 20170081400 - Poulton; Lynn Dorothy ; et al. | 2017-03-23 |
| Polypeptide Constructs And Uses Thereof App 20160367695 - Wilson; David S. ; et al. | 2016-12-22 |
| Antibodies Against TL1a and Uses Thereof App 20160333104 - Poulton; Lynn Dorothy ; et al. | 2016-11-17 |
| Interferon Alpha 2b Variants App 20160122410 - Behrens; Collette ; et al. | 2016-05-05 |
| Anti-cd38 Antibodies And Fusions To Attenuated Interferon Alpha-2b App 20160068612 - Clarke; Adam ; et al. | 2016-03-10 |
| Anti-IL-23 heterodimer specific antibodies Grant 9,127,057 - Clarke , et al. September 8, 2 | 2015-09-08 |
| Humanized antibodies with anti-tumor activity Grant 8,901,279 - Clarke , et al. December 2, 2 | 2014-12-02 |
| ANTIBODIES TO CD1d App 20140286957 - Nambiar; Jonathan Kannan ; et al. | 2014-09-25 |
| ANTIBODIES AGAINST TL1a AND USES THEREOF App 20140255302 - Poulton; Lynn Dorothy ; et al. | 2014-09-11 |
| Polypeptide Constructs And Uses Thereof App 20140248238 - Wilson, JR.; David S. ; et al. | 2014-09-04 |
| Humanized Antibodies with Anti-Tumor Activity App 20130280246 - Clarke; Adam W. ; et al. | 2013-10-24 |
| Humanised antibodies with anti-tumour activity Grant 8,470,320 - Clarke , et al. June 25, 2 | 2013-06-25 |
| Anti-il-23 Heterodimer Specific Antibodies App 20130115166 - Clarke; Adam William ; et al. | 2013-05-09 |
| Pharmaceutical Manufacturing Process App 20120258939 - Miller; John ; et al. | 2012-10-11 |
| Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions Grant 8,178,519 - Miller , et al. May 15, 2 | 2012-05-15 |
| Humanised Antibodies With Anti-tumour Activity App 20100297134 - Clarke; Adam W. ; et al. | 2010-11-25 |
| Mass analysis of mobility selected ion populations Grant 7,560,688 - Clowers , et al. July 14, 2 | 2009-07-14 |
| Pharmaceutical Manufacturing Process For Heat Sterilized Glucocorticoid Suspensions App 20080269178 - Miller; John ; et al. | 2008-10-30 |
| Mass analysis of mobility selected ion populations App 20070158543 - Clowers; Brian H. ; et al. | 2007-07-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 